Tam, C. S., & Kamel, S. (2016). Comment on Lipsky et al: Incidence and Risk Factors of Bleeding-Related Adverse Events in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib. Haematologica.
استشهاد بنمط شيكاغوTam, Constantine S., و Sarah Kamel. "Comment On Lipsky Et Al: Incidence and Risk Factors of Bleeding-Related Adverse Events in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib." Haematologica 2016.
MLA استشهادTam, Constantine S., و Sarah Kamel. "Comment On Lipsky Et Al: Incidence and Risk Factors of Bleeding-Related Adverse Events in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib." Haematologica 2016.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.